Compare moats
Up to three covered companies, band by band. Every call is a curated editorial judgment, never a disclosed figure — and every band carries its cited basis.
| NetApp | Tempus AI | Ciena | |
|---|---|---|---|
| Moat rating | narrow The FY2026 10-K shows a real, durable lock but not an unassailable one. On the durable side: "Our cloud storage services are based on the same ONTAP data management software that underpins our on-premises ONTAP storage infrastructure offerings", and the same filing's income statement shows the company holding a gross margin near 71% across all three reported years - $4,433M on $6,268M in FY2024, $4,613M on $6,572M in FY2025 and $4,899M on $6,925M in FY2026 - while revenue grew from $6,268M to $6,925M and income from operations widened from 19% to 24% of net revenues. Holding that margin through the memory-cost shock the same filing discloses is the commercial evidence the lock is worth something. On the limiting side, the filing says competition "is intense", that in public cloud "customers may choose native cloud services that are consumed as operating expenses", and that "New competitors or alliances among existing competitors could emerge and quickly gain significant market share" - and IDC's 1Q26 external-storage tracker (Blocks & Files, 2026-06-16, cited on the AFF/ASA product row below) ranks NetApp second behind Dell, not first. | narrow The FY2025 10-K documents a real asset: a network "connected in some way to more than 55% of all oncologists practicing in the United States" and "more than 65% of all academic medical centers," via "more than 700 unique data connections" across "more than 5,000 healthcare institution sites," with "broad data rights, including the rights to longitudinally updated data." Not eroding: revenue $693.4M to $1,271.8M (+83%), net loss narrowed from $705.8M to $245.0M. Not wide: still loss-making against "an accumulated deficit of $2.4 billion," with payment received on only "approximately 55% of our clinical oncology NGS tests and 50% of our hereditary tests." | narrow Ciena's FY2025 10-K describes a technology position that has held but does not lock customers in. On the durable side, the strategy is to "build on and expand our global leadership in optical networking", resting on "our proprietary WaveLogic™ coherent modem technology" and approximately 2,400 issued patents with 800 more pending as of December 2, 2025. On the limiting side, the same filing says competition "remains intense" and features "aggressive selling efforts, including using significant pricing pressure to displace incumbent vendors", that "our customer contracts generally do not include minimum or guaranteed purchases", and that "there is no assurance that we will maintain our incumbency". Concentration cuts the same way: the five largest customers contributed approximately 50% of fiscal 2025 revenue, one cloud provider approximately 18%. Its income statement reports gross profit of $1,878.9M on $4,386.5M of revenue in FY2023, $1,719.6M on $4,015.0M in FY2024 and $2,004.9M on $4,769.5M in FY2025. Self-described leadership in its segments, with customers that are re-won deal by deal, is a narrow moat. |
| Moat type | switching costs The FY2026 10-K makes the source of the advantage explicit and it is the cost of leaving the data-management layer, not a network or a patent estate. The same ONTAP software runs the on-premises arrays and the cloud services ("Our cloud storage services are based on the same ONTAP data management software that underpins our on-premises ONTAP storage infrastructure offerings"), and the AFF family "allows customers to connect to clouds for more data services, data tiering, caching, and disaster recovery". A customer's volume layout, snapshot and replication workflow and operating tools therefore carry from the array into Azure, AWS and Google rather than being abandoned at the cloud boundary — the filing describes NetApp as "the only provider of enterprise-grade storage services natively embedded in the world's largest public cloud providers", so the usual moment of escape is instead the moment the relationship renews. | network effects The filing states the mechanism: "Each product line is designed to enable and enhance the other, thereby creating network effects." That is the filing's own characterisation, so the rating rests on corroborating facts: 700+ data connections across 5,000+ sites with longitudinal rights; roughly 801,000 tests in FY2025 (about 340,500 Oncology) feeding the records Insights licenses; Insights working with "19 of the 20 largest public pharmaceutical companies based on 2024 revenue" at "approximately 126%" net revenue retention. Intangibles fit less well: the xT PMA, ADLT status, Paige's clearance and five CAP/CLIA labs are real, but named peers hold comparable approvals. | intangibles ip The FY2025 10-K locates the advantage in owned technology rather than in customer lock-in: "The success of our business and technology leadership depends significantly on our proprietary and internally developed technology." That technology is centred on WaveLogic, which Ciena's fiscal Q3 2026 earnings presentation (the source of the first two product rows below) defines as "Ciena's proprietary family of coherent optical chips — the core technology inside most of our networking products", and it reaches beyond Ciena's own systems: the 10-K's coherent pluggable transceivers use WaveLogic "for use within our systems and third-party equipment". Switching costs are the weaker candidate, because the same filing describes operators disaggregating line systems from modems and competitors using price to displace incumbents. |
| Leadership | co leader IDC's 1Q26 external enterprise storage systems tracker, as reported by Blocks & Files on 2026-06-16 (cited in full on the AFF/ASA product row below), ranks NetApp second worldwide behind Dell and ahead of Everpure, Huawei and HPE, attributing the placing to "its growing all-flash business and cloud-integrated data management". Second of five ranked vendors, in a market whose leader is someone else, is a shared front rank rather than an owned one - and the distinct claim NetApp makes in the FY2026 10-K is positional rather than volumetric: being "the only provider of enterprise-grade storage services natively embedded in the world's largest public cloud providers". | at parity The filing claims no ranked lead; its positional language is hedged, as in "one of the largest sequencers of cancer patients... in the United States." Two disclosures cut the other way: the reimbursement goal is to become "more in line with other NGS providers who have adopted similar strategies, such as FMI and Guardant," and competitors "may have longer operating histories; larger customer bases; greater brand recognition and market penetration." Competition names Foundation Medicine (Roche), Caris, Guardant, Natera, Neogenomics, Quest, LabCorp, Flatiron, IQVIA, ConcertAI and major CROs, all unranked. Scaled positions on both sides support parity, not a top position. | co leader Slide 6 of Ciena's fiscal Q3 2026 earnings presentation of 2026-09-03 (https://s25.q4cdn.com/550667411/files/content_files/Ex-99-2-2026-Q3-Earnings-Presentation_FINAL-1.pdf) lists "#1 in Data Center Interconnect Globally" (Dell'Oro Group), "#1 in Total Optical Networking in N. America" (Cignal AI, Dell'Oro Group, Omdia) and "#1 in Submarine Networks Globally" (Omdia), with market share measured as of Q2 2026 excluding China, and a caveat that Ciena "has not independently verified" the analyst data. On the company's own presentation of that data, that is the front rank in its core segments, but the presentation does not claim the global lead in total optical networking, and the FY2025 10-K says competition is "dominated by a small number of very large, multi-national companies" - Nokia, Huawei, Cisco, Hewlett Packard Enterprise and ZTE - many of which have "substantially greater financial, operational and marketing resources, and broader product offerings". A shared front rank, led by Ciena where the company-reported rankings measure it, rather than an uncontested one. |
| Pricing power | moderate It holds price rather than raising it. On the figures filed with the FY2026 10-K, gross margin was 70.7% of revenue in FY2024 ($4,433M on $6,268M), 70.2% in FY2025 ($4,613M on $6,572M) and 70.7% in FY2026 ($4,899M on $6,925M) - flat across three years in which revenue grew from $6,268M to $6,925M - and it held that level while absorbing a component-cost shock. It is no stronger than that because the filing's own risk factor lists "competitive pricing, customer price sensitivity" and "pricing and discounting pressures" among the drivers of gross margin, and discloses that the company "experienced inflationary pressure and supply chain constraints beginning in the second half of fiscal 2026, resulting in increased costs for memory and other components, which have affected our gross margins" - a cost shock it is absorbing rather than fully passing on. | weak Diagnostics prices are administered: after a CPT code is set, "CMS, establish payment levels and coverage rules under Medicare," delegating to MACs, while "Private payers establish their rates and coverage rules independently." Average revenue per Oncology test rose from about $1,510 to about $1,600, "driven primarily by increased Medicare reimbursement rates" — the payer moved the price. Collection came on "approximately 55% of our clinical oncology NGS tests and 50% of our hereditary tests," and payer "cost-saving initiatives... are likely to result in pricing pressures." The moderate pocket is confined to Data and applications ($316.4M of $1,271.8M). | moderate Moderate, and improving. The FY2025 10-K's income statement reports gross profit of $1,878.9M on $4,386.5M, $1,719.6M on $4,015.0M and $2,004.9M on $4,769.5M of revenue for FY2023-FY2025, in a market where, the filing says, rivals use "significant pricing pressure to displace incumbent vendors" and "price and total cost of ownership" heads the list of competitive factors. Since then the AI build-out has lifted gross margin: Ciena's fiscal Q3 2026 earnings presentation (https://s25.q4cdn.com/550667411/files/content_files/Ex-99-2-2026-Q3-Earnings-Presentation_FINAL-1.pdf) reports GAAP gross margin of 45.4% against 41.3% a year earlier, on revenue up 37% year over year, and guides fiscal 2027 adjusted gross margin to 45% to 46%. The presentation does not say how much of that is price rather than mix or volume, and the 10-K warns that AI-related demand has led to "a constrained supply environment" that can raise component costs. |
| Summary | NetApp sells storage hardware but the asset is ONTAP, the data-management software that has run its arrays for over three decades and now also runs inside the three largest public clouds as a first-party service. The FY2026 10-K organises the company into two segments, Hybrid Cloud (AFF and ASA all-flash arrays, AFX for AI workloads, FAS hybrid-flash, E/EF-Series, StorageGRID object storage) and Public Cloud (Azure NetApp Files, Amazon FSx for NetApp ONTAP, Google Cloud NetApp Volumes, Cloud Volumes ONTAP), and states that both rest on the same ONTAP software. That is the whole argument: an enterprise that has standardised its snapshots, replication and multiprotocol access on ONTAP carries those habits with it when it moves workloads to a hyperscaler, and NetApp is paid on both sides of the move. The evidence that the lock has commercial value is the margin's steadiness: across the three years the FY2026 10-K reports, gross margin sat at 70.7%, 70.2% and 70.7% of revenue ($4,433M on $6,268M, $4,613M on $6,572M, $4,899M on $6,925M) while revenue grew, and the filing's own percentage-of-revenue table shows no mix shift doing that work - product and services held near 46% and 54% of revenue throughout. The limits are equally in the filing. NetApp is second, not first: IDC's 1Q26 tracker puts it behind Dell in external enterprise storage, and the 10-K's competition section concedes that cloud providers are simultaneously partners and rivals, that consumption models "may reduce overall demand for our traditional on-premises offerings sold through a capital expenditure (capex) model", and that alternative architectures "may reduce or eliminate demand for some of our offerings". Component exposure is real too: the filing discloses "inflationary pressure and supply chain constraints beginning in the second half of fiscal 2026, resulting in increased costs for memory and other components, which have affected our gross margins", and names NAND among the components whose supply can tighten. This is a durable second place built on software stickiness, not a structural monopoly. | Tempus AI's durable asset is an installed provider network and the longitudinal data rights attached to it, not any single assay: connections to more than 55% of practicing U.S. oncologists and more than 65% of academic medical centers, 700+ data connections across 5,000+ institution sites. That network makes the linked clinical-molecular database sellable — Insights serves 19 of the 20 largest public pharmaceutical companies by 2024 revenue at roughly 126% net revenue retention, and the trial network (1,400+ trials signed, 40,000+ patients identified) depends on the sequencing base. Economics are improving: revenue up 83% to $1.27B, net loss down from $705.8M to $245.0M. It stops short of wide on the filing's own terms — a $2.4B accumulated deficit, payment on only ~55% of oncology and ~50% of hereditary tests, and Diagnostics prices set by CMS, MACs and private payers. | Ciena is the optical-transport specialist among networking vendors - its fiscal Q3 2026 earnings presentation calls it "the only pure-play optical systems provider operating at scale today" - and its FY2025 10-K builds the business on one proprietary technology, the WaveLogic coherent modem, carried into the 6500 Packet-Optical Platform, Waveserver data center interconnect systems, the 6500 RLS photonic line system and coherent pluggable transceivers sold for Ciena's own systems and third-party equipment. Analyst rankings the company cites in that presentation, which it says it "has not independently verified", put Ciena first in data center interconnect globally, in total optical networking in North America and in submarine networks globally (Q2 2026, excluding China). The AI build-out has turned it into more of a cloud supplier than a telecom one: cloud providers were 53% of fiscal Q3 2026 revenue, revenue rose 37% year over year, and GAAP gross margin reached 45.4%. The 10-K is equally clear about why the position is narrow rather than wide. Competition is "dominated by a small number of very large, multi-national companies", many with greater resources; rivals use pricing to displace incumbents; contracts carry no minimum or guaranteed purchases; the five largest customers were about half of fiscal 2025 revenue; and disaggregation lets an operator buy the line system from one vendor and the modem from another, while the push into data-center interconnects brings Ciena up against Marvell, Credo and Broadcom. |
| Chain position | NetApp sits between the memory supply and the enterprise data centre. Upstream, the FY2026 10-K says "Third-party component costs make up a significant portion of our product costs" and singles out NAND as hard to manage "if supplies of certain components, including NAND, become limited relative to demand". Downstream, the hyperscalers are channel, partner and rival at once: the filing states "We both partner with and compete against cloud service providers through our cloud-based software and services offerings", while Azure NetApp Files, Amazon FSx for NetApp ONTAP and Google Cloud NetApp Volumes are delivered as those clouds' own natively embedded services. Distribution is a mix of direct sales and "an ecosystem of partners, including the leading cloud providers". | Tempus sits between clinical care and pharma R&D. It ingests data from 5,000+ institution sites, runs five CAP/CLIA labs (Chicago, Atlanta, Raleigh, Aliso Viejo, Minneapolis via OneOme), and sells Diagnostics to providers and payers ($955.4M FY2025, +111%, administered) and Data and applications to pharma ($316.4M, +31%, negotiated). The clinical output is the data business's input. | Ciena sits between optical-component suppliers and the operators building AI-era networks. Upstream, its FY2025 10-K says its products include "optical and electronic components for which reliable, high-volume supply is often available only from sole or limited sources", built by contract manufacturers with facilities in Canada, Mexico, Thailand, Vietnam and the United States; at November 1, 2025 it carried $826.2 million of inventory and $2.1 billion of purchase commitments. Downstream, the fiscal Q3 2026 earnings presentation puts direct cloud providers at 53% of the quarter's revenue against 37% for service providers, and describes its products as the links between data centers (data center interconnect) and between distributed AI training clusters ("scale-across"). |
| Products (share / barrier) |
|
|
|
| Long-horizon vote | +0.13 at weight 0.20 · swarm neutral Editorial prior, not backtested. | -0.01 at weight 0.20 · swarm neutral Editorial prior, not backtested. | +0.13 at weight 0.20 · swarm neutral Editorial prior, not backtested. |